Study S000664

Feasibility, Acceptability, and Preliminary Efficacy of Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: An Open-Label Pilot Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07040592
Acronym: HARP
Study type: INTERVENTIONAL
Phase: PHASE2
Masking: NONE
Status: RECRUITING
Enrollment: 30
Start: 2026-01-15
Primary completion: 2027-06-30
Lead sponsor: Yale University
Conditions: Alcohol Use Disorder (AUD); HIV
Interventions: DRUG:semaglutide
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: NIH:1P01AA029545-01

Registered primary outcomes

Proportion of participants who complete enrollment and duration of sessions [12 weeks]
Number of sessions completed [12 weeks]
Adherence to Medication [12 weeks]
Safety of study assessed by adverse event reporting [12 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.